Allan L. Goldstein is Director at REGENERX BIOPHARMACEUTICALS INC (RGRX). They have made 1 open-market trade across 1 company since 2019, most recently 2021-12-08.
CIK 0000905390
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGRX | BUY | 2021-06-30 | 2021-07-06 | $0.20 | $25K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.